The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

BACKGROUND: Schizophrenia is a chronic and debilitating neuropsychiatric disorder that often requires long-term pharmacotherapy to manage symptoms and prevent relapse. Cariprazine is a potent dopamine D(3) and D(2) receptor partial agonist that is FDA-approved in the US for the treatment of schizoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasrallah, Henry A., Earley, Willie, Cutler, Andrew J., Wang, Yao, Lu, Kaifeng, Laszlovszky, István, Németh, György, Durgam, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571492/
https://www.ncbi.nlm.nih.gov/pubmed/28836957
http://dx.doi.org/10.1186/s12888-017-1459-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571492/
https://www.ncbi.nlm.nih.gov/pubmed/28836957
http://dx.doi.org/10.1186/s12888-017-1459-z

Ejemplares similares